Skip to main content
S 3387 114th Congress Senate Health

SAVINGS Act

Introduced: September 22, 2016 Introduced by: Cotton, Tom Republican · Arkansas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 22, 2016
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 22, 2016
Introduced in Senate
 Plain-English summary Congressional Research Service

Safely Advancing Valuable and Inexpensive New Generic Solutions Act or the SAVINGS Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to prioritize the review of certain generic drug applications and act on them within 150 days. This generic fast track review applies to applications for drugs: (1) that are not under patent or for which patents will expire soon, (2) for which there is no marketing exclusivity in effect, and (3) for which a generic has not recently been introduced to the market by more than one manufacturer.

The FDA must report on applications subject to generic fast track review and provide an annual accounting of how it has spent generic drug user fees.
What's happening now September 22, 2016

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1